113 related articles for article (PubMed ID: 17161199)
1. Single nucleotide polymorphism array analysis to predict clinical outcome in neuroblastoma patients.
Hiyama E; Yamaoka H; Kamimatsuse A; Onitake Y; Hiyama K; Nishiyama M; Sueda T
J Pediatr Surg; 2006 Dec; 41(12):2032-6. PubMed ID: 17161199
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.
Scaruffi P; Coco S; Cifuentes F; Albino D; Nair M; Defferrari R; Mazzocco K; Tonini GP
Cancer Genet Cytogenet; 2007 Aug; 177(1):20-9. PubMed ID: 17693187
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma in adolescents: the Italian experience.
Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
[TBL] [Abstract][Full Text] [Related]
4. Overall genomic pattern is a predictor of outcome in neuroblastoma.
Janoueix-Lerosey I; Schleiermacher G; Michels E; Mosseri V; Ribeiro A; Lequin D; Vermeulen J; Couturier J; Peuchmaur M; Valent A; Plantaz D; Rubie H; Valteau-Couanet D; Thomas C; Combaret V; Rousseau R; Eggert A; Michon J; Speleman F; Delattre O
J Clin Oncol; 2009 Mar; 27(7):1026-33. PubMed ID: 19171713
[TBL] [Abstract][Full Text] [Related]
5. High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays.
Carr J; Bown NP; Case MC; Hall AG; Lunec J; Tweddle DA
Cancer Genet Cytogenet; 2007 Jan; 172(2):127-38. PubMed ID: 17213021
[TBL] [Abstract][Full Text] [Related]
6. Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array.
Kamimatsuse A; Matsuura K; Moriya S; Fukuba I; Yamaoka H; Fukuda E; Kamei N; Hiyama K; Sueda T; Hiyama E
Pediatr Blood Cancer; 2009 Jul; 52(7):777-83. PubMed ID: 19260109
[TBL] [Abstract][Full Text] [Related]
7. ArrayCGH-based classification of neuroblastoma into genomic subgroups.
Michels E; Vandesompele J; De Preter K; Hoebeeck J; Vermeulen J; Schramm A; Molenaar JJ; Menten B; Marques B; Stallings RL; Combaret V; Devalck C; De Paepe A; Versteeg R; Eggert A; Laureys G; Van Roy N; Speleman F
Genes Chromosomes Cancer; 2007 Dec; 46(12):1098-108. PubMed ID: 17823929
[TBL] [Abstract][Full Text] [Related]
8. Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression.
Morales La Madrid A; Nall MB; Ouyang K; Minor A; Raca G; Kent P; Miller I; Schleiermacher G; Janoueix-Lerosey I; Cohn SL
Pediatr Blood Cancer; 2013 Feb; 60(2):332-5. PubMed ID: 22997192
[TBL] [Abstract][Full Text] [Related]
9. Risks and benefits of ending of mass screening for neuroblastoma at 6 months of age in Japan.
Tajiri T; Souzaki R; Kinoshita Y; Tanaka S; Koga Y; Suminoe A; Matsuzaki A; Hara T; Taguchi T
J Pediatr Surg; 2009 Dec; 44(12):2253-7. PubMed ID: 20006005
[TBL] [Abstract][Full Text] [Related]
10. Genetics and genomics of neuroblastoma.
Capasso M; Diskin SJ
Cancer Treat Res; 2010; 155():65-84. PubMed ID: 20517688
[TBL] [Abstract][Full Text] [Related]
11. Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study.
Oue T; Inoue M; Yoneda A; Kubota A; Okuyama H; Kawahara H; Nishikawa M; Nakayama M; Kawa K
J Pediatr Surg; 2005 Feb; 40(2):359-63. PubMed ID: 15750929
[TBL] [Abstract][Full Text] [Related]
12. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
Mosse YP; Diskin SJ; Wasserman N; Rinaldi K; Attiyeh EF; Cole K; Jagannathan J; Bhambhani K; Winter C; Maris JM
Genes Chromosomes Cancer; 2007 Oct; 46(10):936-49. PubMed ID: 17647283
[TBL] [Abstract][Full Text] [Related]
13. Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome.
Schramm A; Vandesompele J; Schulte JH; Dreesmann S; Kaderali L; Brors B; Eils R; Speleman F; Eggert A
Clin Cancer Res; 2007 Mar; 13(5):1459-65. PubMed ID: 17332289
[TBL] [Abstract][Full Text] [Related]
14. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
[TBL] [Abstract][Full Text] [Related]
15. Biology of neuroblastomas that were found by mass screening at 6 months of age in Japan.
Kaneko Y; Kobayashi H; Watanabe N; Tomioka N; Nakagawara A
Pediatr Blood Cancer; 2006 Mar; 46(3):285-91. PubMed ID: 16078225
[TBL] [Abstract][Full Text] [Related]
16. Natural antibody against neuroblastoma among Japanese children with or without neuroblastoma.
Fukuda M; Nozaki C; Ishiguro Y; Horibe K
Cancer; 1999 Nov; 86(10):2166-70. PubMed ID: 10570448
[TBL] [Abstract][Full Text] [Related]
17. High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.
Westermann F; Henrich KO; Wei JS; Lutz W; Fischer M; König R; Wiedemeyer R; Ehemann V; Brors B; Ernestus K; Leuschner I; Benner A; Khan J; Schwab M
Clin Cancer Res; 2007 Aug; 13(16):4695-703. PubMed ID: 17652624
[TBL] [Abstract][Full Text] [Related]
18. Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. NB Screening Study Group.
Sawada T; Shikata T; Matsumura T; Kawakatsu H; Sugimoto T
Prog Clin Biol Res; 1994; 385():371-5. PubMed ID: 7972233
[No Abstract] [Full Text] [Related]
19. Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma.
Mora J; Lavarino C; Alaminos M; Cheung NK; Ríos J; de Torres C; Illei P; Juan G; Gerald WL
Genes Chromosomes Cancer; 2007 Apr; 46(4):385-96. PubMed ID: 17243159
[TBL] [Abstract][Full Text] [Related]
20. Multilocus loss of heterozygosity allelotypes identify a genetic pathway associated with progression from low to high stage disease in neuroblastoma.
Chughtai SA; Genus T; Ramani P; Dyer S; Powell JE; McMullan D; Davison V; McConville CM;
Eur J Cancer; 2006 Aug; 42(12):1826-34. PubMed ID: 16872824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
